Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine transporters are membrane proteins responsible for the regulated movement of adenosine across cell membranes. Adenosine itself cannot freely diffuse through biological membranes, so these specialized transporters are essential for controlling extracellular and intracellular adenosine concentrations. This regulation is crucial because adenosine plays key roles in cellular signaling, energy metabolism, and tissue protection. There are two main gene families encoding adenosine transporter proteins: Equilibrative Nucleoside Transporters (ENTs) and Concentrative Nucleoside Transporters (CNTs). ENTs mediate bidirectional transport, while CNTs mediate active uptake coupled to sodium gradients. Different subtypes have distinct expression patterns and inhibitor sensitivities, influencing purinergic signaling, drug pharmacokinetics, and tissue protection.
Inhibition of adenosine transport
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Transporter (ENT/CNT).